Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Sana Biotechnology Q2 EPS $(0.39) Down From $(0.32) YoY

Sana Biotechnology Q2 EPS $(0.39) Down From $(0.32) YoY

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.

byBill Haddad

August 4, 2022

1 minute read

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.

Earnings

A Preview Of iQIYI’s Earnings

By Benzinga Insights

August 21, 10:00 AM

iQIYI (NASDAQ:IQ) is set to give its latest quarterly earnings report on Tuesday, 2023-08-22. Here’s what investors need…

M&A
News

Choice Hotels Said Remains Confident In Completing Its Combination With Wyndham Hotels & Resorts Within A Year

By Charles Gross

January 10, 8:57 AM

Choice Hotels International, Inc. (NYSE:CHH) (the "Company" or "Choice"), today issued an investor presentation and infographic disputing the false and misleading antitrust claims made by Wyndham

CHH

ENDRA Life Sciences Q3 EPS $(0.05), Inline

By Benzinga Newsdesk

November 14, 5:18 PM

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.

NDRA